Clinical trial IRT software solutions are purpose-built platforms that manage interactive response technology functions in clinical research — primarily participant randomization and investigational product supply management. Selecting the right IRT software has direct consequences for data integrity, regulatory compliance, supply chain efficiency, and overall trial timelines.
The clinical trial IRT software market has matured considerably over the past decade. Early systems were primarily focused on telephone-based randomization with limited supply management capabilities. Current IRT software solutions are web-based, configurable platforms that integrate randomization and supply management within a single validated environment.
Configurable vs. Custom-Built IRT Software
A fundamental distinction among clinical trial IRT software solutions is whether the platform uses a configurable architecture or requires custom development for each study.
Configurable IRT software solutions allow sponsors and CROs to define their trial’s randomization design, supply algorithms, eligibility criteria, visit schedules, and dispensing rules through a structured interface — without writing or modifying underlying software code. This approach typically produces shorter implementation timelines, more predictable validation processes, and lower per-study costs than custom-built alternatives.
Custom-built IRT software requires development work for each new protocol, which extends implementation timelines and increases the complexity of the validation process. For highly unusual protocol designs that fall outside what configurable platforms can accommodate, custom development may be necessary. For the majority of clinical trial types, a well-designed configurable platform is sufficient.
Randomization Design Support
The randomization capabilities of an IRT software solution must match the design specified in the trial protocol. Sponsors should confirm that the platform supports their required randomization method before selecting it.
Standard randomization methods — simple block and stratified block randomization — are supported by virtually all clinical trial IRT software solutions. More complex designs require specific platform capabilities: minimization algorithms, response-adaptive randomization, Bayesian adaptive designs, and multi-arm multi-stage (MAMS) frameworks each place distinct demands on the IRT software’s randomization engine.
Protocol amendments that change the randomization design mid-study are among the most technically demanding IRT software operations. Confirming that a platform can implement such amendments efficiently — with appropriate documentation and without disrupting ongoing enrollment — is an important but often overlooked selection criterion.
Supply Management Functionality
Effective clinical trial IRT software solutions use real-time enrollment and dispensing data to drive supply chain decisions. Rather than operating from static projections, the supply management engine continuously updates its forecasts as actual enrollment data accumulates, triggering resupply orders and expiry alerts based on current inventory status at each site.
Key supply management capabilities to evaluate include: lot-level inventory tracking, expiry management with configurable alert thresholds, multi-depot and multi-site support, temperature excursion flagging, drug return and destruction workflow management, and integration with external clinical supply management systems.
Global Trial Requirements
Multi-regional clinical trials place additional demands on IRT software solutions. Country-specific labeling regulations, local language requirements, site-level protocol variations, and multi-depot supply networks all need to be accommodated within the platform’s configuration capabilities.
Some IRT software solutions handle global trial requirements natively through configurable country and site-level settings. Others require manual workarounds or custom development for multi-regional deployments. For sponsors running global programs, confirming the platform’s international capabilities is essential during the selection process.
Validation and Regulatory Documentation
Every clinical trial IRT software solution used in a GCP-regulated study must have current, complete validation documentation. This includes the validation master plan, user requirements specifications, design specifications, test protocols, test results, and deviation reports. Sponsors should request this documentation during the vendor selection process and review it against the applicable regulatory standards for their target submission regions.
Vendor-supplied validation documentation covers the platform itself. Protocol-specific validation — confirming that the specific configuration deployed for a given study performs as intended — is conducted during the implementation phase and must be completed before first-patient-in.
The RTSM platform for clinical trials represents one approach to integrated IRT software functionality, combining randomization and supply management within a single configurable, validated environment.